NCT03678571已完成不适用
Latrunculin A for Oocyte Vitrification
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 400
- 试验地点
- 3
- 主要终点
- survival after thawing
研究概览
简要总结
Using cytoskeleton Stabilizer the Latrunculin A would improve the outcome of oocyte vitrification
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 42 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •indication for oocyte cryopreservation
排除标准
- 未提供
研究组 & 干预措施
Vitrification medium with no supplementation
No Intervention
Latrunculin A supplemented vitrification medium
Experimental
干预措施: Latrunculin A supplemented vitrification medium (Other)
结局指标
主要结局
survival after thawing
时间窗: 6 days after thawing
次要结局
- fertilization rate(6 days of culture)
- Rates of blastocyst formation and quality(6 days of culture)
- embryo utilization rate(6 days of culture)
- clinical pregnancy rate(three months)
- ongoing pregnancy rate(12 months)
研究者
Muhammad Fawzy
IVF Lab Director
Ibn Sina Hospital
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Oocyte Vitrification Aided With Cytochalasin BInfertilityNCT03678558Ibn Sina Hospital612
招募中
不适用
Vitrification of Oocytes Matured by CAPA-IVMFertility PreservationNCT06157619Centro de Fertilidad y Reproducción Asistida, Peru20
已完成
不适用
Oocyte Vitrification for In Vitro Fertilization (IVF) Patients and Women With Fertility Threatening ConditionsFertility PreservationNCT01448460University of Louisville8
已完成
Unknown
Investigation of methods to prevent oocyte degeneration in minimally invasive ICSIoneJPRN-UMIN000050410Kusuhara Women's Clinic170
已完成
早期 1 期
Effect of Oocyte Vitrification on Fertilization Rate, Embryo Quality and DevelopmentFertilityNCT01422395Main Line Fertility Center40